Table 1.

Clinical and pathologic characteristics of the Caucasian population (n = 526)

CharacteristicsLocalized prostate cancer
Age at diagnosis, y
 Mean63.3
 SD6.8
 Range43.5–80.7
Follow-up median (months)88.8
N (%)
Biochemical recurrence (%)130 (24.7)
PSA at diagnosis (ng/mL)
 ≤10362 (69)
 >10–20103 (20)
 >2056 (11)
Pathologic Gleason score
 ≤6158 (31)
 7244 (48)
 ≥8107 (21)
Pathologic T stage
 pT = T2313 (60)
 pT = T3195 (37)
 pT = T413 (3)
Nodal invasion
 N0481 (92)
 N+44 (8)
Neoadjuvant hormonotherapy
 Yes31 (6)
 No495 (94)
Adjuvant hormonotherapy
 Yes30 (6)
 No496 (94)
Margin status
 Negative368 (70)
 Positive154 (30)

Abbreviations: PSA, prostate-specific antigen; T, tumor; N, node.